This Article  • Full text PDF  • Correction  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Gideon Koren, MD, ABMT, FRCPC; Anne Pastuszak, MSc
The Hospital for Sick Children Toronto, Ontario

JAMA. 1993;270(18):2178.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

In Reply.

—We thank Dr Tueth for his comments and agree with the notion that a new era has started in clinical teratology. The prospective studies on lithium and fluoxetine organized by us could be conducted with over 100 patients each because there are now Teratology Information Services in both the United States and Canada that prospectively and systematically collect exposure data in pregnancy. We believe that in the next decade it will be possible to shed light on the reproductive safety and risk of many medications that are currently in the "gray zone" of animal studies and a few case reports. As a word of caution, however, it will be important not to overinterpret the present results to the area of behavioral teratology. It will be crucial to prove that babies exposed in utero to fluoxetine are not different in their various domains of development (cognitive, language, and the . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?